학술논문

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’
Document Type
Article
Source
In: Annals of Hematology. (Annals of Hematology, August 2022, 101(8):1727-1739)
Subject
Language
English
ISSN
14320584
09395555